|
Oncogenes and Tumor Suppressors
Citations 181-190 of 795 total displayed.
|
Past content
(since May 2000):
|
The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells
- Karl J. Aichberger, Matthias Mayerhofer, Anja Vales, Maria-Theresa Krauth, Karoline V. Gleixner, Martin Bilban, Harald Esterbauer, Karoline Sonneck, Stefan Florian, Sophia Derdak, Winfried F. Pickl, Hermine Agis, Andras Falus, Christian Sillaber, and Peter Valent
Blood 2006; 108: 3538-3547.
[Abstract]
[Full text]
[PDF]
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation
- Peter J. Campbell, E. Joanna Baxter, Philip A. Beer, Linda M. Scott, Anthony J. Bench, Brian J. P. Huntly, Wendy N. Erber, Rajko Kusec, Thomas Stauffer Larsen, Stéphane Giraudier, Marie-Caroline Le Bousse-Kerdilès, Martin Griesshammer, John T. Reilly, Betty Y. Cheung, Claire N. Harrison, and Anthony R. Green
Blood 2006; 108: 3548-3555.
[Abstract]
[Full text]
[PDF]
NUP214-ABL1 in adult T-ALL: the GMALL study group experience
- Thomas Burmeister, Nicola Gökbuget, Richard Reinhardt, Harald Rieder, Dieter Hoelzer, and Stefan Schwartz
Blood 2006; 108: 3556-3559.
[Abstract]
[Full text]
[PDF]
Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia
- Elise Chapiro, Lisa Russell, Isabelle Radford-Weiss, Christian Bastard, Michel Lessard, Stephanie Struski, Helene Cave, Sandra Fert-Ferrer, Carole Barin, Odile Maarek, Veronique Della-Valle, Jonathan C. Strefford, Roland Berger, Christine J. Harrison, Olivier A. Bernard, and Florence Nguyen-Khac, the Groupe Francophone de Cytogénétique Hématologique
Blood 2006; 108: 3560-3563.
[Abstract]
[Full text]
[PDF]
Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera
- Takefumi Ishii, Edward Bruno, Ronald Hoffman, and Mingjiang Xu
Blood 2006; 108: 3128-3134.
[Abstract]
[Full text]
[PDF]
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice
- Yupo Ma, Wei Cui, Jianchang Yang, Jun Qu, Chunhui Di, Hesham M. Amin, Raymond Lai, Jerome Ritz, Diane S. Krause, and Li Chai
Blood 2006; 108: 2726-2735.
[Abstract]
[Full text]
[PDF]
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia
- Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, William G. Woods, Beverly J. Lange, David A. Sweetser, Jerald P. Radich, Irwin D. Bernstein, and Soheil Meshinchi
Blood 2006; 108: 2764-2769.
[Abstract]
[Full text]
[PDF]
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model
- Thomas Mercher, Gerlinde Wernig, Sandra A. Moore, Ross L. Levine, Ting-Lei Gu, Stefan Fröhling, Dana Cullen, Roberto D. Polakiewicz, Olivier A. Bernard, Titus J. Boggon, Benjamin H. Lee, and D. Gary Gilliland
Blood 2006; 108: 2770-2779.
[Abstract]
[Full text]
[PDF]
A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK
- Mohamad Fawal, Florence Armstrong, Severine Ollier, Henri Dupont, Christian Touriol, Bernard Monsarrat, Georges Delsol, Bernard Payrastre, and Dominique Morello
Blood 2006; 108: 2780-2788.
[Abstract]
[Full text]
[PDF]
Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma
- Yajun Han, Hesham M. Amin, Bevin Franko, Christine Frantz, Xinzhe Shi, and Raymond Lai
Blood 2006; 108: 2796-2803.
[Abstract]
[Full text]
[PDF]
|
|
